Aquazide 25 mg Sun Pharmaceuticals Industries

£132.00

Aquazide 25 mg by Sun Pharmaceuticals represents a well-characterized dermatological research compound for investigating skin depigmentation mechanisms in laboratory models.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Aquazide 25 mg Sun Pharmaceuticals Industries
Aquazide 25 mg Sun Pharmaceuticals Industries
£132.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Aquazide — Research Summary

Aquazide 25 mg is a pharmaceutical-grade dermatological compound manufactured by Sun Pharmaceuticals Industries for in-vitro research applications. This standardized formulation provides researchers at Stroid UK Shop with a consistent reference material for investigating skin pigmentation pathways and melanin synthesis inhibition mechanisms. The compound offers excellent stability and reproducibility for controlled laboratory studies examining dermatological biochemistry and cellular pigment regulation processes.

Laboratory Applications

Research scientists utilise Aquazide 25 mg to examine tyrosinase enzyme inhibition pathways and melanocyte function in cell culture models. The compound serves as a valuable tool for investigating hyperpigmentation disorders, studying melanin biosynthesis mechanisms, and evaluating cellular responses to depigmentation agents. Laboratory studies focus on understanding how this compound affects melanocyte proliferation, tyrosinase activity modulation, and melanin transfer processes. Researchers within our dermatological research collection frequently combine these investigations with studies using compounds from our SARMs category and peptides range to explore multi-pathway cellular interactions.

Technical Specifications

Aquazide 25 mg Research Specifications
Parameter Specification
Active Content 25 mg per unit
Manufacturer Sun Pharmaceuticals Industries
Form Pharmaceutical tablet
Purity Pharmaceutical grade
Storage Conditions Room temperature, dry environment
Research Applications Dermatological studies, pigmentation research

Compliance Information

Aquazide 25 mg is supplied exclusively for legitimate scientific research purposes in properly equipped laboratory facilities. This pharmaceutical-grade compound is intended for in-vitro studies only and must not be used for human consumption, therapeutic applications, or any purpose outside controlled research environments. Researchers must comply with all applicable laboratory safety protocols and institutional guidelines when handling this material. This product is not intended for diagnostic, therapeutic, or preventive applications in humans or animals.

Related